INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2003

Low vitamin D and high parathyroid hormone levels were linked to an increased risk of sarcopenia in older adults.

In the Longitudinal Aging Study Amsterdam, researchers investigated whether baseline serum 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) were associated with sarcopenia over 3 years in adults aged 65 and older. After adjustment for confounders, participants with low baseline 25-OHD (<25 nmol/liter) were 2.57 (95% CI 1.40-4.70, based on grip strength) and 2.14 (95% CI 0.73-6.33, based on muscle mass) times more likely to experience sarcopenia compared to those with high levels (>50 nmol/liter). High PTH levels (≥4.0 pmol/liter) were associated with an increased risk of sarcopenia compared with low PTH (<3.0 pmol/liter) based on grip strength (OR 1.71, 95% CI 1.07-2.73) and muscle mass (OR 2.35, 95% CI 1.05-5.28). Associations were similar in men and women.

Shows an association, not proof of cause and effect.

Study type
Prospective cohort study
Who was studied
Men and women aged 65 years and older (n=1008 for grip strength, n=331 for muscle mass)
What was measured
Sarcopenia (loss of grip strength >40% or loss of muscle mass >3%) over 3 years

THE PAPER

Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.

Visser M, Deeg DJ, Lips P, Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab, 2003.

PubMed 14671166 ↗DOI 10.1210/jc.2003-030604 ↗

Nutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.